Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 1998

View Archived Issues

Inex R&D pipeline update

Cellegy and 3M combine technologies

CoCensys initiates phase II migraine study with ganaxolone tablets

Orphan drug status granted to Endorex's ImmTher for Ewing's sarcoma

SciClone's lead cystic fibrosis drug found safe in phase I

Elan completes acquisition of Carnrick

Neuprex receives orphan drug designation for treatment of severe meningococcal disease

rAd-p53 in gene therapy of cancers with p53 mutation; overview of gene therapies in development

Schering-Plough acquires Canadian rights to Ribi's melanoma theraccine

VIMRx updates stockholders at annual meeting

Ventana Genetics reports novel method for identification of drug target sites

Melphalan derivative pinpointed for further study

Biovail granted license to Celgene's ADHD treatment

New class of FPTase inhibitors discovered at Merck & Co.

Astra prepares another series of immunomodulatory peptides

Tricyclic antitumor compounds developed at Schering-Plough

Modulators of drug/multidrug resistance from Lilly

RPR acquires worldwide rights to Novartis anticoagulant

Phase II trial with HGP-30W HIV vaccine begins in The Netherlands

Elan/Neurex merger nears completion

Antisense therapy for CMV retinitis receives priority review status from FDA

Roche reviews HIV product pipeline in time for AIDS conference

Amur's AM-454 blocks progression of type II diabetes in preclinical studies

Preclinical studies with doranidazole summarized

Two-year landmark study demonstrates importance of initiating triple therapy simultaneously

Pyrazoloacridine evaluated in patients with pancreatic and hepatobiliary cancer

Various schedules and doses of DMDC explored in phase I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...